Brief: Newamsterdam Pharma Announces Pricing Of Upsized Secondary Offering Of Ordinary Shares
07/06/2023 04:30
June 6 (Reuters) - NewAmsterdam Pharma Company NV
NAMS.O :
* NEWAMSTERDAM PHARMA ANNOUNCES PRICING OF UPSIZED SECONDARY
OFFERING OF ORDINARY SHARES
* NEWAMSTERDAM PHARMA - PRICING OF PREVIOUSLY ANNOUNCED
UNDERWRITTEN PUBLIC OFFERING OF 13.9 MILLION SHARES AT PUBLIC
OFFERING PRICE OF $11.50 PER SHARE
Source text for Eikon: ID:nGNXbX0HrG
Further company coverage: NAMS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewAmsterdam Pharma
See all newsBrief: Menarini Group & Newamsterdam Pharma Receive European Commission Approval For Ubeslo And Evlarco
Amgen falls after Novartis trial setback, BMO downgrade
Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Newamsterdam Pharma Company N.V. - Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
Brief: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)